The rules ofsteroid nomenclature originate from a discussion held at the Ciba Foundation in London, England, in 1950 between the representatives of many schools. These were published in Chem. & Ind. (1951) , pp. SN 1-11, and also in French and German. They were subsequently taken over by the International Union of Pure and Applied Chemistry and published in an official form in the aompte8 rendub of the Zurich meeting in 1952 [also I UPAC Nomenclature of Organic Chemi8try, Section8 A and B, 1957, lst ed. 1958; 2nd ed. 1966, pp. 71-82 . London: Butterworths; and numerous reprints and translations, including J. Amer. chem. Soc. (1960) 82, [5577] [5578] [5579] [5580] [5581] .
In 1960 a group of specialists under the chairmanship of Professor T. Reichstein, including representatives of the IUPAC Commissions of the Nomenclature of Organic Chemistry and of Biochemical Nomenclature, met in Basle, Switzerland, for discussions of amendments and additions to the Rules. Agreement was not reached on all the points discussed, and the results of this meeting were therefore published in discussion form in the JUPAC Information Bulletin, no. 11. They have generally been referred to as the 'Basle Proposals'.
Since then, many points in the Basle proposals have become almost universally accepted in the literature. In 1965 the two International Commissions concerned, namely the IUPAC Commission of the Nomenclature of Organic Chemistry and the Commission on Biochemical Nomenclature (now jointly responsible to IUPAC and IUB), decided that the time had come for as many as possible of the Basle Proposals to be formulated as rules.
The present Rules include: all the original Rules, mostly renumbered (with additions and amendments arising from the Basle Proposals or from current practice in the literature); and most of the Basle Proposals, namely those that have been generally accepted. Further, adoption of the sequence-rule procedure [R. S. Cahn, C. K. Ingold & V. Prelog, Angew. Chem. int. Ed. (1966) . 5, 385 (in English) ; Angew. Chem. (1966) . 78,413 (in German); for a partial simplified account see R. S. Cahn, J. chem. Educ. (1964) . 41, 116] for general stereochemical descriptions in much of the chemical literature has permitted its introduction now also for some sections of steroid nomenclature that were previously in dispute or intractable. Decisions on a few of the Basle Proposals have, however, been postponed; it is hoped that further experience will indicate the most appropriate ways of dealing with them. 
NOMENCLATURE OF STEROIDS
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1.2. If one or more of the carbon atoms shown in (1) is not present and a steroid name is used, the numbering of the remainder is undisturbed.
1.3. For a steroid the name, including stereochemical affixes, and its structural formula (see Rule 2S-1.4), denote the absolute configuration at each asymmetric centre (see also Rule 2S-1.5). When the configuration at one or more centres is not known, this is indicated by Greek letter(s) 6 (xi) prefixed by the appropriate numeral(s).
1.4. When the rings of a steroid are denoted as projections on to the plane of the paper, the formula is normally to be oriented as in (2) shown to the right of C-20 are termed ac and those to the left are termed /3. ( 7) 5a-Pregnan-2oc-ol* Notes: (1) The 20ac/20/3-nomenclature is continued because of long tradition. When a longer side chain is present at C-17 the sequence-rule procedure (see references cited in the Introduction) is more generally convenient (see Rule 2S-1.7) and it may also be used to designate stereochemistry at C-20 in pregnanes, being particularly useful for 20-substituents that may cyclize with a substituent at another position [e.g. carboxylic acids as in example (12)]. For 20-hydroxy-, 20-alkoxy-, 20-acyloxy-, 20-amino-and 20-halogeno-derivatives of pregnane without a substituent on C-17 or C-21, 200c-is equivalent to (20S)-, and 20/3-to (20R)-; however, these equivalences are sometimes reversed when additional substituents are present, e.g. on C-17 or C-21, and in such cases the references cited in the Introduction should be consulted.
(2) When stereochemistry at C-20 is denoted by a Fischer-type projection, as in (6)- (11) or for cardenolides as (37) or bufanolides as (43), the 17,20-bond is preferably denoted by an ordinary line; the stereochemistry at C-17 is then adequately denoted by a thick or a broken bond to the H or to the other substituent (e.g. OH) at position 17. In such formulae, representing the 17,20-bond by a thick or a broken line cannot be correct for both C-17 and C-20; this has, however, frequently been done, then involving the additional convention that the way in which this bond is written is neglected when considering the stereochemistry at C-20.
1.7. The stereochemistry at C-20 and other positions in steroid side chains longer than ethyl is Vol. 113 7 Notes: (1) The sequence-rule procedure is also used when the side chain is cyclized (see Rules 2S-3.3 and 2S-3.4).
(2) The backbone of a 17-side chain is best denoted as in the plane ofthe paper (lines of ordinary thickness), the 17,20-bond being similarly denoted. (-20MC) Except for pregnane derivatives, stereochemistry due to substituents on the chain is then indicated by the customary thick or broken lines denoting bonds that project, respectively, above and below the plane of the paper.
Fundamental carbocycle8
Rule 2S-2 (expandedfrom Rule8 S-3.1 to S-3.5).
2.1. The parent tetracyclic hydrocarbon without methyl groups at C-10 and C-13 and without a side chain at C-17 is named 'gonane'.
2.2. The hydrocarbon with a methyl group at C-13 but without a methyl group at C-10 and without a side chain at C-17 is named 'estrane'. 
5/9-Estrane / Note: Names of compounds having a methyl group attached to C-10 and a hydrogen atom attached to C-13 are to be based on 18-norandrostane (see Rules 2S-2.3 and 2S-7.1) and not on 10-methylgonane.
2.3. The following names are used for the hydro-8 1969
carbons (20) and (21) with methyl groups at both C-10 and C-13. (27) 5sc-Lanostane (25) 5ef,I3140-Pregna-6,8,yi Itrien-2o-yn-3a01-o (b) The names 'cholane ',' cholestane', ' ergostane' and 'stigmastane' imply the configuration at C-20 shown in partial formula (26); this is (20R) except for some derivatives containing additional substituents (cf. Notes to Rule 2S-1.6). (28) Notes: Several other methods have been used in the past for designating stereochemistry at C-22 and C-25 in the spirostans and related series; all involve serious difficulties (cf. the Basle Proposals, JUPAC Information Bulletin, no. 11; also L. F. Fieser & M. Fieser (1959) . The Steroid8, chapter 21. New York: Reinhold). The sequence-rule procedure is adopted in these Rules because it gives an unequivocal symbolism.
It is to be noted that, although ring E, like rings A, B, C and D, can conveniently be shown by projection on to the plane of the paper, yet ring F cannot be adequately represented in this way since the oxygen atom, C-26, C-24 and C-23 lie in one plane that is perpendicular to the plane of the paper. Ring F is conveniently drawn as in formulae (47)-(51); in formula (47), for instance, the broken line from C-22 to oxygen denotes that the oxygen atom and C-26 of ring F lie behind the plane of the paper and that consequently C-23 and C-24 lie in front of the plane of the paper (configuration R at C-22). In partial formula (48) the configuration at C-22 is reversed and must be stated in the name (S). It is conventional to draw ring F as a chair, but this conformation is not implied in the name 'spirostan'; whatever the conformation of ring F, C-27 and the 25-hydrogen atom both lie in the plane of the paper and so cannot be denoted by broken or thickened lines or designated oc or ,B. In (47) the methyl group is axial (above the general plane of ring F), and in (48) it is equatorial (in the general plane of ring F); in both these cases the configuration at C-25 is S, but this identity of R,S designation arises only because the configuration at C-22 has also been reversed between (47) and (48); a 25R-configuration is shown in (51). The wavy lines in (49) denote unspecified or unknown configurations at both C-22 and C-25.
The R,S specification may also be affected by substituents attached to ring F or C-27, as in compounds (A) and (B). Notes: For the benefit of the specialist, those rules of general substitutive nomenclature that apply most often to steroids are outlined here. For full detail the IUPAC Rules cited above should be consulted.
I. Unsaturation is indicated by changing terminal '-ane' to 'ene', '-adiene', ' -yne' etc., or '-an' to '-en', '-adien', '-yn' etc.; e.g. 5ax-cholest-6-ene, 5,B-cholesta-7,9(11)-diene, 5-spirosten; see also the names of examples (22)- (25). [For uniformity with the IUPAC Rules cited above, the conventions of Chemical Ab8tract8 are used also in the present Rules for the position of locants (positional numerals) and designation of unsaturation. In such matters, and in use of A (Greek capital delta) to designate unsaturation (which is not recommended by IUPAC), authors should respect the house customs of the journals to which their papers are submitted.] II. Most substituents can be designated either as suffixes or as prefixes; a few can be named only as prefixes, the commonest of these being halogens, alkyl and nitro groups. When possible, one type of substituent must be designated as suffix. When more than one type is present that could be designated as suffix, one type only may be so expressed and the other types must be designated as prefixes. Choice for suffix is made according to an order of preference that is laid down in the Rules cited above; the most important part of this order, for steroids, is as follows, in decreasing preference: 'onium salt, acid, lactone, ester, aldehyde, ketone, alcohol, amine, ether. Suffixes are added to the name of the saturated or unsaturated parent system, the terminal 'e' of '-ane', '-ene', '-yne', '-adiene' etc. being elided before a vowel (presence or absence ofnumerals has no effect on such elisions).
The following examples illustrate the use of these principles.
(a) Acids. Suffix for -CH3 -COOH: -oic acid
Suffix for CH C-COOH: -carboxylic acid Examples: 11-Oxo-5a-cholan-24-oic acid (20S)-3a-Hydroxy-5-pregnene-20-carboxylic acid (b) Lactones, other than cardanolides and bufanolides. The ending '-ic acid' or '-carboxylic acid' of the name of the hydroxy acid is changed to '-lactone' or '-carbolactone' respectively, 5fl-Androstan-3-one 5-Pregnene-3,20-dione 1l-Oxo-5a-cholan-24-oic acid (g) Alcohols. Suffix: -ol.
Prefix: hydroxy-. Examples: 5f-Cholestane-3, 11 -diol 3a-Hydroxy-5oc-androstan-17-one Notes: (1) Composite suffixes -olone and -onol, to denote simultaneous presence of hydroxyl and ketonic groups, are not permitted by IUPAC Rules and should not be used.
(2) A few trivial names exist for hydroxy ketones, such as testosterone for 17fl-hydroxy-4-androsten- 113, 9,10-Seco-5,7,10(19)-cholestatrien-3f-ol (for seco see Rule Note: If these trivial names are used as a basis for naming derivatives or stereoisomers, the derived trivial name must make the nature of the modification completely clear and is preferably accompanied at first mention by the full systematic name. For example, in steroid papers 'epi' is often used with trivial names to denote inversion at one centre; the name '1l-epicortisol' defines the compound fully since cortisol is already defined as the 1ll,-alcohol; but the name 'epicortisol' does not define the compound and is inadequate.
4.3. Androstane-17-carboxylic acids may be called 'etianic acids', although the former (systematic) name is preferred. The orientation of the hydrogen atoms at positions 5 and 17 must in all cases be indicated as 50c or 5,, and 17(ocH) 
5a-Androstane-I7a-carboxylic acid (systematic) or 50c,I7(fH)-etianic-acid (trivial) 17 NOMENCLATURE OF STEROIDS Stereochemical modiftcation8 Rule 2S-5 (extended version of Rule S-5). 5.1. If, as for instance in a synthetic compound, there is stereochemical inversion at all the asymmetric centres whose configurations do not require to be specified in a name, the italicized prefix ent-(a contracted form of enantio-) is placed in front of the complete name of the compound. This prefix denotes inversion at all asymmetric centres (including those due to named substituents) whether these are cited separately or are implied in the name.
Examples: ent-I 7fl-Hydroxy-4-androsten-3-one (ent-Testosterone) Note: When Roman or Arabic numerals are used to enumerate formulae, the prefix ent may be used to indicate the enantiomer. Thus, e.g., (65) above may be designated (ent-64).
5.2. If there is stereochemical inversion at a minority of the asymmetric centres whose configurations do not require to be specified in a name, the configuration of the hydrogen atoms or substituents at the affected bridgeheads, or the carbon chain (if any) at position 17, are stated by means of a prefix or prefixes a or ,B, each with its appropriate positional numeral, placed before the stem name laid down in the preceding Rules.
Examples:
